AR230449A1 - Procedimiento para preparar nuevos acidos dicarboxilicos derivados de piranoquinolina - Google Patents

Procedimiento para preparar nuevos acidos dicarboxilicos derivados de piranoquinolina

Info

Publication number
AR230449A1
AR230449A1 AR278695A AR27869579A AR230449A1 AR 230449 A1 AR230449 A1 AR 230449A1 AR 278695 A AR278695 A AR 278695A AR 27869579 A AR27869579 A AR 27869579A AR 230449 A1 AR230449 A1 AR 230449A1
Authority
AR
Argentina
Prior art keywords
pyranoquinoline
derived
procedure
preparing new
dicarboxyl acids
Prior art date
Application number
AR278695A
Other languages
English (en)
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Application granted granted Critical
Publication of AR230449A1 publication Critical patent/AR230449A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/90Oxygen atoms with acyclic radicals attached in position 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
AR278695A 1978-10-31 1979-10-30 Procedimiento para preparar nuevos acidos dicarboxilicos derivados de piranoquinolina AR230449A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7842679 1978-10-31
GB7920760 1979-06-14

Publications (1)

Publication Number Publication Date
AR230449A1 true AR230449A1 (es) 1984-04-30

Family

ID=26269406

Family Applications (1)

Application Number Title Priority Date Filing Date
AR278695A AR230449A1 (es) 1978-10-31 1979-10-30 Procedimiento para preparar nuevos acidos dicarboxilicos derivados de piranoquinolina

Country Status (32)

Country Link
US (1) US4419352A (es)
AR (1) AR230449A1 (es)
AT (1) AT379811B (es)
AU (1) AU528648B2 (es)
BR (1) BR7907006A (es)
CA (1) CA1142520A (es)
CH (1) CH643264A5 (es)
CS (1) CS231166B2 (es)
CU (1) CU21123A (es)
DD (1) DD146954A5 (es)
DE (1) DE2943658A1 (es)
DK (1) DK458679A (es)
FI (1) FI67702C (es)
FR (1) FR2440371A1 (es)
GR (1) GR73861B (es)
HK (1) HK66185A (es)
HU (1) HU183087B (es)
IE (1) IE49464B1 (es)
IL (1) IL58579A (es)
KE (1) KE3540A (es)
LU (1) LU81841A1 (es)
MA (1) MA18631A1 (es)
MY (1) MY8500439A (es)
NL (1) NL7907916A (es)
NO (1) NO154522C (es)
NZ (1) NZ191956A (es)
PH (1) PH15442A (es)
PL (1) PL130691B1 (es)
PT (1) PT70392A (es)
SE (1) SE451071B (es)
SG (1) SG40885G (es)
SU (1) SU1014476A3 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260306A (en) * 1981-07-24 1993-11-09 Fisons Plc Inhalation pharmaceuticals
GB8402047D0 (en) * 1984-01-26 1984-02-29 Fisons Plc Nitrogen heterocycles
DE3584580D1 (de) * 1984-04-13 1991-12-12 Fisons Plc Formen und formulierungen des nedocromil-natriumsalzes.
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
GB8607159D0 (en) * 1986-03-22 1986-04-30 Smith & Nephew Ass Pharmaceutical composition
HU202753B (en) * 1986-06-21 1991-04-29 Sandoz Ag Process for producing retard pharmaceutical compositions containing cetotiphene
USRE38628E1 (en) * 1986-12-23 2004-10-19 Fisons Plc Pharmaceutical compositions
DE3787274T2 (de) * 1986-12-23 1994-01-27 Fisons Plc Pharmazeutische Präparate, die eine wässerige Lösung eines Pyranoquinolins enthalten.
USH672H (en) 1986-12-31 1989-09-05 E. R. Squibb & Sons, Inc. Stable antifungal capsule formulation
US4767612A (en) * 1987-01-23 1988-08-30 Rorer Pharmaceutical Corporation Triamcinolone acetonide for the treatment of allergic rhinitis
GB8704089D0 (en) * 1987-02-21 1987-03-25 Fisons Plc Method of treatment
GB2202145B (en) * 1987-03-17 1991-01-02 Fisons Plc Compositions of nedocromil for dermatological use.
US5648084A (en) * 1990-02-28 1997-07-15 Guttag; Alvin Multiple dosage medicine drop bottle
AU650036B2 (en) * 1990-07-25 1994-06-09 Teijin Limited Benzopyran derivative, production thereof, and pharmaceutical composition containing the same
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
US5453431A (en) * 1993-10-29 1995-09-26 Gilman; Andrew L. Use of hydroxychloroquine for treatment of graft-versus-host disease
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
US5891472A (en) * 1996-11-19 1999-04-06 Meri Charmyne Russell Treatment of equine laminitis
US5989571A (en) * 1997-07-23 1999-11-23 Millenium Pharmaceutical Technologies, Inc. Contact dermatitis pharmaceutical preparation with anti-histamine and anti-inflammatory
US5885550A (en) * 1998-07-02 1999-03-23 Vallier; Deandra K. Ophthalmic whitening solution
US7101547B1 (en) 1999-01-22 2006-09-05 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance P by using anti-substance P antibodies
AU2001264616A1 (en) * 2000-05-17 2001-11-26 Cor Therapeutics, Inc. Methods for producing amino substituted chromanes and intermediates therefor
US9132116B2 (en) 2004-08-02 2015-09-15 Willowcroft Pharm Inc. Mast cell stabilizers to prevent or treat laminitis
GB0524808D0 (en) * 2005-12-05 2006-01-11 Novartis Ag Organic compounds
DE102007028095A1 (de) * 2007-06-19 2009-01-15 Bachmann, Vincent Zubereitung zur Behandlung von Hufrehe bei Equiden
FR2924344B1 (fr) * 2007-12-04 2010-04-16 Pf Medicament Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4.
EP2424527B8 (en) * 2009-04-29 2019-07-17 Willowcraft Pharm Inc. Mast cell stabilizers to prevent or treat laminitis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1504709A (en) * 1974-12-07 1978-03-22 Fisons Ltd N-substituted quinolinone-2-carboxyl. acid der
US4143042A (en) * 1977-03-08 1979-03-06 Takeda Chemical Industries, Ltd. 1-azaxanthone-3-carboxylic acids
IL54614A (en) * 1977-05-04 1983-07-31 Fisons Ltd Dihydrodioxo-pyranoquinoline dicarboxylic acid derivatives,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CS735979A2 (en) 1984-02-13
ATA701479A (de) 1985-07-15
NO154522C (no) 1986-10-08
HU183087B (en) 1984-04-28
NO793469L (no) 1980-05-02
SU1014476A3 (ru) 1983-04-23
US4419352A (en) 1983-12-06
MA18631A1 (fr) 1980-07-01
CH643264A5 (fr) 1984-05-30
PH15442A (en) 1983-01-18
AT379811B (de) 1986-03-10
NZ191956A (en) 1984-05-31
DD146954A5 (de) 1981-03-11
IE49464B1 (en) 1985-10-16
PT70392A (en) 1979-11-01
DE2943658A1 (de) 1980-05-14
CA1142520A (en) 1983-03-08
SG40885G (en) 1986-05-02
NL7907916A (nl) 1980-05-02
BR7907006A (pt) 1980-07-15
FI67702C (fi) 1985-05-10
KE3540A (en) 1985-07-12
MY8500439A (en) 1985-12-31
FI793369A (fi) 1980-05-01
GR73861B (es) 1984-05-08
AU5228779A (en) 1980-05-08
FI67702B (fi) 1985-01-31
CU21123A (es) 1982-08-28
PL130691B1 (en) 1984-08-31
AU528648B2 (en) 1983-05-05
SE451071B (sv) 1987-08-31
NO154522B (no) 1986-06-30
LU81841A1 (fr) 1980-05-07
PL219304A1 (es) 1980-12-01
FR2440371A1 (fr) 1980-05-30
DE2943658C2 (es) 1991-08-01
IL58579A0 (en) 1980-01-31
CS231166B2 (en) 1984-10-15
HK66185A (en) 1985-09-13
SE7908995L (sv) 1980-05-01
FR2440371B1 (es) 1983-01-28
DK458679A (da) 1980-05-01
IE792074L (en) 1980-04-30
IL58579A (en) 1985-12-31

Similar Documents

Publication Publication Date Title
AR230449A1 (es) Procedimiento para preparar nuevos acidos dicarboxilicos derivados de piranoquinolina
MX5449E (es) Procedimiento para preparar acidos hidroxidifosfonicos
AR219150A1 (es) Procedimiento para preparar nuevos derivados de aminoazucares
ES490112A0 (es) Procedimiento de preparar oxazolidinationas
MX6255E (es) Procedimiento para preparar benzamidas substituidas
MX5973E (es) Procedimiento para preparar compuestos cefem
DK446179A (da) Fremgangsmaade til fremstilling af substituerede 1-carbadethiapen-2-em-3-carboxylsyrer
ES490504A0 (es) Procedimiento para preparar nuevos compuestos de tiadiazoli-lo
MX5604E (es) Procedimiento para preparar aril-hidantoina
ES485399A0 (es) Procedimiento para preparar pastillas de glucosidos cardioactivos
AR231635A1 (es) Procedimiento para preparar acidos azabiciclicos
ES492032A0 (es) Procedimiento para preparar compuestos de cefem
MX5545E (es) Procedimiento para producir acidos tiometil delta3-cefem-4-carboxilicos 7-(substituido)amino-3-substituidos
IT8047797A0 (it) Procedimento per preparare d-alfaamminoacidi
AR226446A1 (es) Procedimiento para preparar derivados de acidos fenilalcanoicos
MX5724E (es) Procedimiento para preparar metil eteres de cetoximas sustituidas
AR230624A1 (es) Procedimiento para preparar omega-arcil(propionil o butiril)-l-prolinas substituidas
MX6291E (es) Procedimiento para preparar derivados de n-bencilhalogenoacetamida
MX149268A (es) Procedimiento para preparar acidos diperoxidicarboxilicos alifaticos
DK149473C (da) Fremgangsmaade til fremstilling af aminomethan-phosphonsyrer
AR229152A1 (es) Procedimiento para obtener derivados de acidos de 1-tioalcanoilprolina
IT1122386B (it) Procedimento per preparare isopropenil-fenolo
ES478787A0 (es) Procedimiento para preparar acidos fenilalcanoicos.
ES483447A0 (es) Procedimiento para la obtencion de acidos azulmicos quimica-mente estabilizados
ES525714A0 (es) Procedimiento para preparar acidos fenoxialcanoicos